Unfortunately, we don't support Internet Explorer anymore as it has been replaced by Microsoft Edge. Please try using Edge or an alternative modern browser for the best experience.
Dr. David Pass brings over 25 years of extensive commercial success and deep clinical expertise across the therapeutic areas of diabetes, obesity, and cardiovascular disease. He previously led the Diabetes Franchise Alliance between Eli Lilly and Boehringer Ingelheim where he was instrumental in establishing and scaling a multi-billion-dollar franchise. He served as the COO and CCO at Gelesis, and just prior to joining AltrixBio he was president of Glooko’s Life Science business. His broad experience spans pharmaceuticals, medical devices, and innovative healthcare technology solutions. He has established a strong track record of driving commercial success and advancing patient care through a blend of scientific understanding, market acumen, and strategic partnerships.
